This is a powerful medicine used to treat certain types of cancer. It works by stopping cancer cells from growing by interfering with their DNA.
Every report comes from a Lived member, sent anonymously.
Have you tried Fluorouracil (5-FU) for Colorectal Cancer?
Fluorouracil, often called 5-FU, is a chemotherapy medicine that has been in use in the United States since the 1960s. It comes in two very different forms. Given into a vein, it treats several cancers that start in gland-forming tissue (adenocarcinomas): cancers of the colon and rectum, breast, stomach and pancreas. It is usually combined with other cancer medicines, and oncologists also use it for some other cancers, such as cancers of the esophagus, head and neck, and cervix. As a cream or solution applied to the skin, sold as Efudex, Tolak and generic versions, fluorouracil treats actinic keratoses (also called solar keratoses): rough, scaly or crusted patches caused by years of sun exposure. The 5% strength is also used for superficial basal cell carcinoma, a shallow form of a common skin cancer, when standard treatments are impractical, for example with many lesions or a hard-to-treat location. For a single basal cell carcinoma that is easy to reach, surgery remains the preferred treatment because it is almost always successful. The two forms share an active ingredient but differ greatly in dose, side effects and precautions. Most of what follows about blood counts and infusion side effects applies to the intravenous form.
Cells must copy their DNA before they divide. Fluorouracil closely resembles one of the natural building blocks cells use for this. Inside the body it is converted into active forms that block thymidylate synthase, an enzyme needed to make DNA, and that are also built into DNA and RNA by mistake. The damage falls hardest on cells that divide quickly. That is why it works against cancer, and also why its common side effects show up in other fast-renewing tissues: the bone marrow, the lining of the mouth and gut, and the skin. In colorectal and pancreatic cancer, fluorouracil is usually given with leucovorin, a form of folic acid that strengthens both its effect on cancer and its side effects. Much of each dose is broken down by an enzyme called DPD (dihydropyrimidine dehydrogenase). People whose DPD works poorly, usually because of inherited variants in the DPYD gene, clear fluorouracil slowly and can have severe or even fatal reactions to a standard dose. On the skin, fluorouracil targets the fast-growing abnormal cells in sun-damaged patches. The treated area becomes inflamed as those cells die, then heals over with new skin. Only a small amount reaches the bloodstream when it is used on actinic keratoses as directed.
Intravenous fluorouracil is given by an oncology team, either as a quick injection (a bolus), as a continuous infusion, or both. A common schedule for colorectal and pancreatic cancer is a bolus followed by an infusion lasting about 46 hours, repeated every two weeks. The infusion often runs through a central line or port into a small portable pump that people take home, returning to the clinic to have it changed or removed. Breast and stomach cancer regimens use other schedules. The dose is calculated from body size and adjusted for side effects, blood counts and DPD test results. Topical fluorouracil is applied at home. Efudex and its generic equivalents are usually applied twice a day: for 2 to 4 weeks for actinic keratoses, and for at least 3 to 6 weeks, sometimes up to 10 to 12, for superficial basal cell carcinoma. Tolak is applied once a day for 4 weeks to the face, ears or scalp. Apply a thin layer with a glove, nonmetal applicator or fingertips, and wash your hands right afterward. Keep it away from the eyes, eyelids, nose, mouth and other mucous membranes. Avoid sun and tanning lamps during and just after treatment, because ultraviolet light intensifies the reaction. Do not cover treated skin with an airtight dressing unless advised; loose gauze is fine.
With intravenous treatment, common effects include nausea, diarrhea, mouth sores, tiredness, loss of appetite, hair loss and watery eyes. Skin can become dry, darker or more sensitive to the sun. Hand-foot syndrome, which causes tingling, redness, swelling and later peeling on the palms and soles, is more common with continuous infusions, while mouth sores are more common with bolus injections. Fluorouracil also lowers blood counts, with white cells usually at their lowest about 9 to 14 days after a dose. Infections are most likely around then, so people are asked to check their temperature daily. Contact the care team right away for a fever or other signs of infection, severe diarrhea, or mouth sores painful enough to make eating or drinking hard. Report changes in the hands or feet early so the dose can be adjusted before they worsen. Less commonly, fluorouracil affects the heart or the brain. New chest pain, shortness of breath, dizziness or lightheadedness, or new confusion, trouble with balance or coordination, or vision changes need immediate attention: call the care team at once or go to an emergency room. Topical fluorouracil causes a strong reaction on treated skin in nearly everyone: redness, burning or stinging, itching, scaling, crusting and raw, open areas. This is how the treatment works, not a sign that it is failing. Severe itching, or an itchy rash spreading beyond the treated area, can be an allergy to the medicine and should be reported.
Before starting intravenous fluorouracil, people are tested for DPYD gene variants unless treatment is too urgent to wait. People with complete DPD deficiency should not receive it, because no dose has been shown to be safe for them, and people with partial deficiency may need a reduced, individualized dose. A normal result does not rule out serious reactions, since current tests do not detect every variant. Topical fluorouracil should not be used by anyone known to have DPD deficiency; a severe whole-body reaction has been reported after skin use in one such person. Fluorouracil can make warfarin, a blood thinner, much stronger. People taking both need closer INR checks (the international normalized ratio, a blood test of how long blood takes to clot, where a higher number means slower clotting and more bleeding risk). Tell the oncology team about every prescription, over-the-counter medicine and supplement, and about any heart disease, which raises the risk of heart side effects during infusions. Fluorouracil can harm a developing baby. The skin forms should not be used during pregnancy. During intravenous treatment and for 3 months after the last dose, people who could become pregnant, and men with partners who could become pregnant, should use effective contraception. Breastfeeding should stop during intravenous treatment. Topical fluorouracil can be fatal to pets that lick it from skin or chew a tube. Store it out of their reach, keep pets away from treated skin, and clean up or discard any cloth or applicator that has touched it. Tolak contains peanut oil, which is worth raising with the prescriber if you have a peanut allergy.
Intravenous fluorouracil is usually given in repeating cycles over several months, either after surgery or to control cancer that has spread. Blood counts are checked before each cycle, and doses are often delayed or reduced when counts are low or side effects become severe; this is a routine part of treatment rather than a sign it has failed. Some effects build up over time: hand-foot syndrome typically appears after about 8 to 9 weeks of treatment, though it can come sooner. Whether the treatment is working is judged by scans and other tests over time, and results depend on the cancer type, its stage and the medicines combined with fluorouracil. With the cream, the treated skin reddens, then blisters, crusts and wears away before new skin forms. For actinic keratoses, application usually stops once the skin reaches that raw stage. The area can look worse than before for several weeks, and complete healing often takes 1 to 2 months after the last application. Patches that do not clear should be rechecked and may need a biopsy, and people treated for basal cell carcinoma need follow-up visits to confirm the cancer is gone.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Fluorouracil (5-FU), what you've noticed, or ask the community a question.